Login to Your Account



Clinic Roundup


Friday, April 19, 2013
• PledPharma AB, of Stockholm, said its Phase IIa MANAMI trial of mangafodipir in acute myocardial infarction is now fully recruited. The trial is assessing the safety of the PLED substance in patients undergoing coronary angioplasty.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription